Proinflammatory cytokines and hemostatic system in patients with chronic obstructive pulmonary disease

Platelets

Volumn 8, Issue 4, 1997, Pages 255-260

  Ferroni, P ^a   Basili, S ^b   Alessandri, C ^b   Vieri, Marco ^b   Martini, F ^a   Belogi, A ^b   Pulcinelli, F M ^a   Cordova, C ^b   Gazzaniga, Pier Paolo ^a,b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; C REACTIVE PROTEIN; CYTOKINE; FIBRINOGEN; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6;

ADULT; AGED; ARTICLE; BLOOD GAS; CARBON DIOXIDE TENSION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIBRINOGEN BLOOD LEVEL; HEMOSTASIS; HUMAN; HUMAN CELL; MALE; OXYGEN TENSION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; THROMBOCYTE ACTIVATION;

EID: 0030844912     PISSN: 09537104     EISSN: None     Source Type: Journal    
DOI: 10.1080/09537109777294     Document Type: Article

References (21)

1. Kishimoto T. The biology of interleukin-6. Blood 1989; 74: 1-10.
2. Burstein SA. Effects of interleukin-6 on megakaryocytes and on canine platelet function. Stem Cells Dayt 1994; 12: 386-93.
3. Oleksowicz L, Mrowiec Z, Zuckerman D, Isaacs R, Dutcher J, Puszkin E. Platelet activation induced by interleukin-6: evidence for a mechanism involving arachidonic acid metabolism. Thromb Haemostas 1994; 72: 302-8.
4. Oleksowicz L, Paciucci PA, Zuckerman D, Colorito A, Rand JH, Holland JF. Alterations of platelet function induced by interleukin-2. J Immunother 1991; 10: 363-70.
5. Oleksowicz L, Zuckerman D, Mrowiec Z, Puszkin E, Dutcher JP. Effects of interleukin-2 administration on platelet function in cancer patients. Am J Hematol 1994; 45: 224-31.
6. Hawrylowicz CM, Santoro SA, Platt FM, Unanue ER. Activated platlets express IL-1 activity. J Immunol 1989; 143: 4015-18.
7. Sedlmayr P, Blaschitz A, Wilders-Truschnig M, Tiran A, Dohr G. Platelets contain interleukin-1 alpha and beta which are detectable on the cell surface after activation. Scand J Immunol 1995; 42: 209-14.
8. Hawrylowicz CM, Howells GL, Feldmann M. Platelet-derived interleukin-1 induces human endothelial adhesion molecule expression and cytokine production. J Exp Med 1991; 174: 785-90.
9. Kaplanski G, Porat R, Aiura K, Erban JK, Gelfand JA, Dinarello CA. Activated platelets induce endothelial secretion of interleukin-8 in vitro via an interleukin-1-mediated event. Blood 1993; 10: 2492-5.
10. Smyth MJ, Ortaldo RJ. Comparison of the effect of interleukin-2 and interleukin-6 on lytic activity of purified human peripheral blood large granular lymphocytes. J Immunol 1990; 146: 1380-4.
11. Van Snick J. Interleukin-6: an overview. Ann Rev Immunol 1990; 8: 253-78.
12. Castell JV, Gomez-Lechon MJ, David M, Andus T, Geiger T, Trullenque R, Fabra R, Heinrich PC. Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes. FEBS Lett 1989; 242: 237-41.
13. Ferroni P, Basili S, Pulcinelli FM, Pettirossi G, Alessandri C, Violi F, Gazzaniga PP, Cordova C. In vivo thrombin generation and platelet hyperactivity in patients with chronic obstructive pulmonary disease. Platelets 1994; 5: 276-8.
14. Alessandri C, Basili S, Violi F, Ferroni P, Gazzaniga PP, Cordova C and C.O.B.H. Group. Hypercoagulability state in patients with chronic obstructive pulmonary disease. Thromb Haemostas 1994; 72: 343-6.
15. Steele P, Hellis Jr JH, Weily HS. Platelet survival time in patients with hypoxemia and pulmonary hypertension. Circulation 1977; 55: 660-2.
16. Cordova C, Musca A, Violi F, Perrone A, Alessandri C. Long-term oxygen and advanced chronic bronchitis. Lancet 1981; 85: 1098.
17. Wedzicha JA, Syndercombe-Court D, Tan KC. Increased platelet aggregate formation in patients with chronic airflow obstruction and hypoxaemia. Thorax 1991; 46: 504-7.
18. Ferroni P and Gazzaniga PP. Evaluation of the clinical utility of platelet aggregation studies in the long-term follow-up of patients with atherosclerotic vascular disease. J Clin Lab Analysis 1992; 6: 257-63.
19. Schols AMW, Buurman WA, Staal-van den Brekel AJ, Dentener MA, Wouters EFM. Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. Thorax 1996; 51: 819-24.
20. Riise GC, Ahlstedt S, Larsson S, Enander I, Jones I, Larsson P, Andersson B. Bronchial inflammation in chronic bronchitis assessed by measurement of cell products in bronchial lavage fluid. Thorax 1995; 50: 360-5.
21. Humbert M, Monti G, Brenot F, Sitbon O, Portier A, Grangeot-Keros L, Duroux P, Galanaud P, Simonneau G, Emile D. Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension. Am J Respir Crit 1995; 151: 1628-31.